Redeye is still positive on the case as we believe the long-term potential offers good risk reward. The Q2 report was not a blockbuster but shows a stable performance in terms of sales and earnings. We understand that the reorganization within RemaSawco has some short-term impact on business activity. Hence, we are making minor adjustments to our near-term forecasts, but nothing that changes the big picture.
Read more and download the Research Update.
Follow companies at Redeye to receive the latest equity research within Life Science and Technology.
This is a press release from Redeye - Research Powered Investment Banking. www.redeye.se/